FDA Guides Return to Pre-Pandemic Medical Device Enforcement, EUA Policies
The FDA finalized guidance that outlines recommendations regarding the transition of medical device enforcement policies to normal operations
The FDA finalized guidance that outlines recommendations regarding the transition of medical device enforcement policies to normal operations
The FDA granted marketing authorization to Medasense Biometrics’ PMD-200 patient monitor with NOL technology for monitoring nociception.
The U.S. FDA’s Center for Devices and Radiological Health has issued two warning letters to endoscope manufacturer Olympus Medical Systems Corp., following facility inspections.
The FDA finalized guidance that outlines recommendations regarding the transition of medical device enforcement policies to normal operations
The FDA is providing additional information to patients, caregivers, and healthcare providers about two recent issues in certain ventilators.
Read MoreSURGLASSES announced that its Caduceus S AR Spine Navigation System has received 510(k) clearance from the U.S. FDA.
Read MoreThe U.S. FDA has issued a draft guidance to help medical device manufacturers further understand and utilize the Voluntary Summary Malfunction Reporting Program.
Read MoreRF Medical recently received U.S. FDA clearance for its patented MYGEN M-3004 generator and MYOBLA radiofrequency ablation system.
Read MoreThe FDA has cleared Dexcom’s next-generation Dexcom G7 Continuous Glucose Monitoring (CGM) System for people with all types of diabetes.
Read MoreMediPines announced that its FDA-cleared, non-invasive pulmonary gas exchange analyzer, the MediPines AGM100, is now available in Canada.
Read MoreLazurite and Hospital for Special Surgery announced a collaboration based on Lazurite’s ArthroFree Wireless Surgical Camera System.